UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | R | S | T | V | W | X | Z | Ä
Number of items: 469.

A

Abeti, R; Duchen, MR; (2012) Activation of PARP by Oxidative Stress Induced by β-Amyloid: Implications for Alzheimer's Disease. Neurochemical Research 1 - 8.

Abeti, R; Duchen, MR; (2012) Activation of PARP by oxidative stress induced by β-amyloid: implications for Alzheimer's disease. Neurochem Res , 37 (11) pp. 2589-2596. 10.1007/s11064-012-0895-x.

Acharya, S; Nagy, A; Budu, C; Treacy, C; Fearnley, J; Lees, AJ; Giovannoni, G; (2012) The new bradykinesia akinesia incoordination (BRAIN) test: People with Parkinson's disease versus healthy controls. In: MOVEMENT DISORDERS. (pp. S102 - S102).

Ahmed, M; Miller, A; Hanna, MG; Greensmith, L; (2012) Investigating the effects of pharmacological up-regulation of the heat shock response in an in-vitro model of sporadic inclusion body myositis. In: NEUROMUSCULAR DISORDERS. (pp. S26 - S26).

Ahmed, Z; Asi, YT; Sailer, A; Lees, AJ; Houlden, H; Revesz, T; Holton, JL; (2012) The neuropathology, pathophysiology and genetics of multiple system atrophy. Neuropathol Appl Neurobiol , 38 (1) pp. 4-24. 10.1111/j.1365-2990.2011.01234.x.

Ahmed, Z; Revesz, T; Holton, JL; (2012) Neuropathology and pathophysiology of multiple system atrophy Response. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY , 38 (4) 381 - 381. 10.1111/j.1365-2990.2012.01266.x.

Alg, VS; Sofat, R; Houlden, H; Grieve, J; Watkins, LD; Werring, DJ; (2012) Genetic association studies of intracranial aneurysms: systematic review and meta-analysis in over 106 000 individuals. INTERNATIONAL JOURNAL OF STROKE , 7 8 - 8.

Andreasson, U; Portelius, E; Pannee, J; Zetterberg, H; Blennow, K; (2012) Multiplexing and multivariate analysis in neurodegeneration. Methods , 56 (4) pp. 464-470. 10.1016/j.ymeth.2012.02.004.

Andreasson, U; Vanmechelen, E; Shaw, LM; Zetterberg, H; Vanderstichele, H; (2012) Analytical aspects of molecular Alzheimer's disease biomarkers. Biomark Med , 6 (4) pp. 377-389. 10.2217/bmm.12.44.

Angel, TE; Jacobs, JM; Spudich, SS; Gritsenko, MA; Fuchs, D; Liegler, T; Zetterberg, H; (2012) The cerebrospinal fluid proteome in HIV infection: change associated with disease severity. Clin Proteomics , 9 (1) 3-. 10.1186/1559-0275-9-3.

Apaydin, H; Benbir, G; Lees, A; (2012) A stimulus-sensitive tic disorder characterized by echophenomena and coprolalia. Mov Disord , 27 (1) pp. 159-160. 10.1002/mds.23952.

Aviles-Olmos, I; Kefalopoulou, Z; Djamshidian, A; Limousin, P; Dickson, J; Lees, A; Foltynie, T; (2012) An open label, single site, 12 month, phase II, randomised controlled trial evaluating the safety and efficacy of Exendin-4 (Exenatide) in the treatment of patients with moderate severity Parkinson's disease. In: MOVEMENT DISORDERS. (pp. S109 - S109).

B

Bartlett, JW; Frost, C; Mattsson, N; Skillbäck, T; Blennow, K; Zetterberg, H; Schott, JM; (2012) Determining cut-points for Alzheimer's disease biomarkers: statistical issues, methods and challenges. Biomark Med , 6 (4) pp. 391-400. 10.2217/bmm.12.49.

Baruch, N; Duchen, M; Hanna, MG; (2012) Muscle degeneration in ion channel dysfunction. In: NEUROMUSCULAR DISORDERS. (pp. S16 - S16).

Beall, C; Hamilton, DL; Gallagher, J; Logie, L; Wright, K; Soutar, MP; Dadak, S; (2012) Mouse hypothalamic GT1-7 cells demonstrate AMPK-dependent intrinsic glucose-sensing behaviour. Diabetologia , 55 (9) pp. 2432-2444. 10.1007/s00125-012-2617-y.

Bech, S; Hjermind, LE; Salvesen, L; Nielsen, JE; Heegaard, NH; Jørgensen, HL; Rosengren, L; (2012) Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes. Parkinsonism Relat Disord , 18 (1) pp. 69-72. 10.1016/j.parkreldis.2011.08.012.

BenMoyal-Segal, L; Soreq, L; Ben-Shaul, Y; Ben-Ari, S; Ben-Moshe, T; Aviel, S; Bergman, H; (2012) Adaptive Alternative Splicing Correlates with Less Environmental Risk of Parkinsonism. Neurodegenerative Diseases , 9 (2) pp. 87-98. 10.1159/000331328.

Bendlin, BB; Carlsson, CM; Johnson, SC; Zetterberg, H; Blennow, K; Willette, AA; Okonkwo, OC; (2012) CSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease. PLoS One , 7 (6) , Article e37720. 10.1371/journal.pone.0037720. Green open access
file

Benilova, I; Karran, E; De Strooper, B; (2012) The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes. Nat Neurosci , 15 (3) pp. 349-357. 10.1038/nn.3028.

Bezprozvanny, I; Supnet, C; Sun, S; Zhang, H; De Strooper, B; (2012) Response to Shilling et al. (10.1074/jbc.M111.300491). J Biol Chem , 287 (24) 20469-. 10.1074/jbc.L112.356790.

Bis, JC; DeCarli, C; Smith, AV; van der Lijn, F; Crivello, F; Fornage, M; Debette, S; (2012) Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nat Genet , 44 (5) pp. 545-551. 10.1038/ng.2237.

Blennow, K; Hardy, J; Zetterberg, H; (2012) The neuropathology and neurobiology of traumatic brain injury. Neuron , 76 (5) pp. 886-899. 10.1016/j.neuron.2012.11.021.

Blennow, K; Zetterberg, H; Fagan, AM; (2012) Fluid biomarkers in Alzheimer disease. Cold Spring Harb Perspect Med , 2 (9) a006221-. 10.1101/cshperspect.a006221.

Blennow, K; Zetterberg, H; Rinne, JO; Salloway, S; Wei, J; Black, R; Grundman, M; (2012) Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease. Arch Neurol , 69 (8) pp. 1002-1010. 10.1001/archneurol.2012.90.

Borgegård, T; Gustavsson, S; Nilsson, C; Parpal, S; Klintenberg, R; Berg, AL; Rosqvist, S; (2012) Alzheimer's disease: presenilin 2-sparing γ-secretase inhibition is a tolerable Aβ peptide-lowering strategy. J Neurosci , 32 (48) pp. 17297-17305. 10.1523/JNEUROSCI.1451-12.2012.

Brady, S; Squier, W; Hilton-Jones, D; Sewry, C; Hanna, M; Holton, JL; (2012) A histological evaluation of protein accumulation in inflammatory myopathies. In: NEUROMUSCULAR DISORDERS. (pp. S27 - S27).

Brady, S; Squier, W; Hilton-Jones, D; Sewry, C; Holton, JL; (2012) INCLUSION BODY MYOSITIS: A DIAGNOSTIC CHALLENGE. In:

Bras, J; Guerreiro, R; Hardy, J; (2012) Use of next-generation sequencing and other whole-genome strategies to dissect neurological disease. Nat Rev Neurosci , 13 (7) pp. 453-464. 10.1038/nrn3271.

Bras, J; Verloes, A; Schneider, SA; Mole, SE; Guerreiro, RJ; (2012) Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis. Human Molecular Genetics , 21 (12) 2646 - 2650. 10.1093/hmg/dds089. Green open access
filefile

Brinkmalm, G; Portelius, E; Öhrfelt, A; Mattsson, N; Persson, R; Gustavsson, MK; Vite, CH; (2012) An online nano-LC-ESI-FTICR-MS method for comprehensive characterization of endogenous fragments from amyloid β and amyloid precursor protein in human and cat cerebrospinal fluid. J Mass Spectrom , 47 (5) pp. 591-603. 10.1002/jms.2987.

Bromander, S; Anckarsäter, R; Kristiansson, M; Blennow, K; Zetterberg, H; Anckarsäter, H; Wass, CE; (2012) Changes in serum and cerebrospinal fluid cytokines in response to non-neurological surgery: an observational study. J Neuroinflammation , 9 242-. 10.1186/1742-2094-9-242.

Brouillette, J; Caillierez, R; Zommer, N; Alves-Pires, C; Benilova, I; Blum, D; De Strooper, B; (2012) Neurotoxicity and memory deficits induced by soluble low-molecular-weight amyloid-β1-42 oligomers are revealed in vivo by using a novel animal model. J Neurosci , 32 (23) pp. 7852-7861. 10.1523/JNEUROSCI.5901-11.2012.

Bruno, D; Pomara, N; Nierenberg, J; Ritchie, JC; Lutz, MW; Zetterberg, H; Blennow, K; (2012) Levels of cerebrospinal fluid neurofilament light protein in healthy elderly vary as a function of TOMM40 variants. Exp Gerontol , 47 (5) pp. 347-352. 10.1016/j.exger.2011.09.008.

Buchhave, P; Minthon, L; Zetterberg, H; Wallin, AK; Blennow, K; Hansson, O; (2012) Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. Arch Gen Psychiatry , 69 (1) pp. 98-106. 10.1001/archgenpsychiatry.2011.155.

Burge, J; Schorge, S; Hanna, MG; (2012) Progesterone reduces and shifts the voltage dependence of the skeletal muscle chloride conductance. In: NEUROMUSCULAR DISORDERS. (pp. S16 - S16).

Burge, JA; Hanna, MG; (2012) Novel insights into the pathomechanisms of skeletal muscle channelopathies. Curr Neurol Neurosci Rep , 12 (1) pp. 62-69. 10.1007/s11910-011-0238-3.

Burke, A; Mantuano, E; Bhatia, KP; Veneziano, L; Giunti, P; (2012) NOVEL DE NOVO MUTATION CAUSING BENIGN HEREDITARY CHOREA WITH HYPOTHRYOIDISM AND A PITUITARY MASS. In: (pp. A11-A11).

C

Cai, J; Qi, X; Kociok, N; Skosyrski, S; Emilio, A; Ruan, Q; Han, S; (2012) β-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment. EMBO Mol Med , 4 (9) pp. 980-991. 10.1002/emmm.201101084.

Camargos, S; Lees, AJ; Singleton, A; Cardoso, F; (2012) DYT16: The original cases. Journal of Neurology, Neurosurgery and Psychiatry , 83 (10) pp. 1012-1014. 10.1136/jnnp-2012-302841.

Camargos, S; Lees, AJ; Singleton, A; Cardoso, F; (2012) DYT16: the original cases. J Neurol Neurosurg Psychiatry , 83 (10) pp. 1012-1014. 10.1136/jnnp-2012-302841.

Cambray, S; Arber, C; Little, G; Dougalis, AG; de Paola, V; Ungless, MA; Li, M; (2012) Activin induces cortical interneuron identity and differentiation in embryonic stem cell-derived telencephalic neural precursors. Nature Communications , 3 p. 841. 10.1038/ncomms1817.

Cardoso, F; Vale, T; Lees, A; (2012) Gowers' Queen Square Case Notes on Chorea. In: NEUROLOGY.

Carmeliet, P; De Strooper, B; (2012) Alzheimer's disease: A breach in the blood-brain barrier. Nature , 485 (7399) pp. 451-452. 10.1038/485451a.

Casas, JP; Hingorani, AD; (2012) The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet , 379 (9822) 1214 - 1224. 10.1016/S0140-6736(12)60110-X. Green open access
file

Chan, MV; Bubb, KJ; Noyce, A; Villar, IC; Duchene, J; Hobbs, AJ; Scotland, RS; (2012) Distinct endothelial pathways underlie sexual dimorphism in vascular auto-regulation. Br J Pharmacol , 167 (4) pp. 805-817. 10.1111/j.1476-5381.2012.02012.x.

Charlesworth, G; Gandhi, S; Bras, JM; Barker, RA; Burn, DJ; Chinnery, PF; Gentleman, SM; (2012) Tau acts as an independent genetic risk factor in pathologically proven PD. Neurobiology of Aging , 33 (4) 10.1016/j.neurobiolaging.2011.11.001.

Charlesworth, G; Gandhi, S; Bras, JM; Barker, RA; Burn, DJ; Chinnery, PF; Gentleman, SM; (2012) Tau acts as an independent genetic risk factor in pathologically proven PD. Neurobiol Aging , 33 (4) 838.e7-838.11. 10.1016/j.neurobiolaging.2011.11.001.

Charlesworth, G; Gandhi, S; Bras, JM; Gentleman, SM; Guerreiro, R; Hardy, J; Holton, JL; (2012) First stage association analysis of neuropatholically proven PD confirms MAPT as an independent risk factor for PD. In: MOVEMENT DISORDERS. (pp. S450 - S451).

Charlesworth, G; Plagnol, V; Holmström, KM; Bras, J; Sheerin, UM; Preza, E; Rubio-Agusti, I; (2012) Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis. The American Journal of Human Genetics , 91 (6) 1041 - 1050. 10.1016/j.ajhg.2012.10.024. Green open access
file

Chung, HY; Machado, P; van der Heijde, D; D'Agostino, MA; Dougados, M; (2012) Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, inflammation and damage, and poorer function and health-related quality of life: results from the DESIR cohort. Ann Rheum Dis , 71 (6) pp. 809-816. 10.1136/annrheumdis-2011-200180.

Chávez-Gutiérrez, L; Bammens, L; Benilova, I; Vandersteen, A; Benurwar, M; Borgers, M; Lismont, S; (2012) The mechanism of γ-Secretase dysfunction in familial Alzheimer disease. EMBO J , 31 (10) pp. 2261-2274. 10.1038/emboj.2012.79.

Clark, CN; Weber, YW; Lerche, H; Warner, TT; (2012) Paroxysmal exercise-induced dyskinesia of the hands. Mov Disord , 27 (12) pp. 1579-1580. 10.1002/mds.25200.

Connick, P; Kolappan, M; Crawley, C; Webber, DJ; Patani, R; Michell, AW; Du, MQ; (2012) Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurol , 11 (2) pp. 150-156. 10.1016/S1474-4422(11)70305-2.

Cooper-Knock, J; Hewitt, C; Highley, JR; Brockington, A; Milano, A; Man, S; Martindale, J; (2012) Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain , 135 (3) 751 - 764. 10.1093/brain/awr365. Green open access
file

Coppola, G; Chinnathambi, S; Lee, JJ; Dombroski, BA; Baker, MC; Soto-Ortolaza, AI; Lee, SE; (2012) Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet , 21 (15) pp. 3500-3512. 10.1093/hmg/dds161.

Corradi, L; Porro, I; Schenone, A; Momeni, P; Ferrari, R; Nobili, F; Ferrara, M; (2012) A repository based on a dynamically extensible data model supporting multidisciplinary research in neuroscience. BMC Medical Informatics and Decision Making , 12 (1) p. 115. 10.1186/1472-6947-12-115. Gold open access

Cortese, A; Machado, P; Miller, A; Brady, S; Hilton-Jones, D; Morrow, J; Hiscock, A; (2012) CLINICAL FEATURES AND CLINICAL COURSE OF SPORADIC INCLUSION BODY MYOSITIS (IBM): A PROSPECTIVE COHORT STUDY: IBM-NET. In:

Cortese, A; Machado, P; Morrow, J; Dewar, L; Hiscock, A; Miller, A; Brady, S; (2012) The natural history of sporadic inclusion body myositis: data from the IBM-Net prospective cohort study. In: (pp. S27-S27).

Cottenie, E; Laura, M; Hanna, M; Dick, D; Blake, J; Houlden, H; Reilly, MM; (2012) Genetic analysis of FIG4 in patients with CMT. In: (pp. S18-S18).

Crehan, H; Hardy, J; Pocock, J; (2012) Microglia, Alzheimer's disease, and complement. Int J Alzheimers Dis , 2012 983640-. 10.1155/2012/983640. Gold open access

Crehan, H; Holton, P; Wray, S; Pocock, J; Guerreiro, R; Hardy, J; (2012) Complement receptor 1 (CR1) and Alzheimer's disease. Immunobiology , 217 (2) pp. 244-250. 10.1016/j.imbio.2011.07.017.

Cremades, N; Cohen, SI; Deas, E; Abramov, AY; Chen, AY; Orte, A; Sandal, M; (2012) Direct observation of the interconversion of normal and toxic forms of α-synuclein. Cell , 149 (5) pp. 1048-1059. 10.1016/j.cell.2012.03.037.

Curtis, HJ; Sibley, CR; Wood, MJ; (2012) Mirtrons, an emerging class of atypical miRNA. Wiley Interdiscip Rev RNA , 3 (5) pp. 617-632. 10.1002/wrna.1122.

D

Daborg, J; Andreasson, U; Pekna, M; Lautner, R; Hanse, E; Minthon, L; Blennow, K; (2012) Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer's disease. J Neural Transm (Vienna) , 119 (7) pp. 789-797. 10.1007/s00702-012-0797-8.

Dale, RC; Gardiner, A; Antony, J; Houlden, H; (2012) Familial PRRT2 mutation with heterogeneous paroxysmal disorders including paroxysmal torticollis and hemiplegic migraine. Dev Med Child Neurol , 54 (10) pp. 958-960. 10.1111/j.1469-8749.2012.04394.x.

Davidson, G; Murphy, S; Polke, J; Laura, M; Salih, M; Muntoni, F; Blake, J; (2012) Frequency of mutations in the genes associated with hereditary sensory and autonomic neuropathy in a UK cohort. J Neurol , 259 (8) pp. 1673-1685. 10.1007/s00415-011-6397-y.

De Strooper, B; Iwatsubo, T; Wolfe, MS; (2012) Presenilins and γ-secretase: Structure, function, and role in Alzheimer disease. Cold Spring Harbor Perspectives in Medicine , 2 (1) 10.1101/cshperspect.a006304.

De Strooper, B; Iwatsubo, T; Wolfe, MS; (2012) Presenilins and γ-secretase: structure, function, and role in Alzheimer Disease. Cold Spring Harb Perspect Med , 2 (1) a006304-. 10.1101/cshperspect.a006304.

De Strooper, B; Scorrano, L; (2012) Close encounter: mitochondria, endoplasmic reticulum and Alzheimer's disease. EMBO J , 31 (21) pp. 4095-4097. 10.1038/emboj.2012.279.

De Strooper, B; Voet, T; (2012) Alzheimer's disease: A protective mutation. Nature , 488 (7409) pp. 38-39. 10.1038/488038a.

Devine, MJ; Kaganovich, A; Ryten, M; Mamais, A; Trabzuni, D; Manzoni, C; McGoldrick, P; (2012) Correction: Pathogenic LRRK2 Mutations Do Not Alter Gene Expression in Cell Model Systems or Human Brain Tissue. PLOS ONE , 7 (1) , Article e22489. 10.1371/annotation/c12e4f9e-5aae-424b-a69f-fddf16976dc5. Green open access
file

Dihanich, S; (2012) MASL1: a neglected ROCO protein. Biochem Soc Trans , 40 (5) pp. 1090-1094. 10.1042/BST20120127.

Ding, S; Riddoch-Contreras, J; Abramov, AY; Qi, Z; Duchen, MR; (2012) Erratum to: Mild stress of caffeine increased mtDNA content in skeletal muscle cells: the interplay between Ca(2+) transients and nitric oxide. J Muscle Res Cell Motil , 33 (5) 339-. 10.1007/s10974-012-9327-4.

Ding, S; Riddoch-Contreras, J; Abramov, AY; Qi, Z; Duchen, MR; (2012) Mild stress of caffeine increased mtDNA content in skeletal muscle cells: the interplay between Ca2+ transients and nitric oxide. J Muscle Res Cell Motil , 33 (5) pp. 327-337. 10.1007/s10974-012-9318-5.

Djamshidian, A; Lees, A; (2012) Impulsive compulsive behaviours in patients with Parkinson's disease treated with dopamine agonists. Focus on Parkinson's Disease , 23 (1) pp. 16-21.

Djamshidian, A; O'Sullivan, SS; Lees, A; Averbeck, BB; (2012) Effects of dopamine on sensitivity to social bias in Parkinson's disease. PLoS One , 7 (3) , Article e32889. 10.1371/journal.pone.0032889. Green open access
file

Djamshidian, A; O'Sullivan, SS; Lees, AJ; Averbeck, BB; (2012) Effects of dopamine on sensitivity to social bias in Parkinson's disease. In: MOVEMENT DISORDERS. (pp. S268 - S268).

Djamshidian, A; O'Sullivan, SS; Sanotsky, Y; Sharman, S; Matviyenko, Y; Foltynie, T; Michalczuk, R; (2012) Decision making, impulsivity, and addictions: Do Parkinson's disease patients jump to conclusions? MOVEMENT DISORDERS , 27 (9) pp. 1137-1145. 10.1002/mds.25105.

Djamshidian, A; O'Sullivan, SS; Sanotsky, Y; Sharman, S; Matviyenko, Y; Foltynie, T; Michalczuk, R; (2012) Decision making, impulsivity, and addictions: do Parkinson's disease patients jump to conclusions? Mov Disord , 27 (9) pp. 1137-1145. 10.1002/mds.25105.

Dobricic, V; Stefanova, E; Jankovic, M; Gurunlian, N; Novakovic, I; Hardy, J; Kostic, V; (2012) Genetic testing in familial and young-onset Alzheimer's disease: mutation spectrum in a Serbian cohort. Neurobiol Aging , 33 (7) 1481.e7-1481.12. 10.1016/j.neurobiolaging.2011.12.007.

Doherty, KM; Noyce, AJ; Silveira-Moriyama, L; Nisbet, A; Quinn, N; Lees, AJ; (2012) Familial camptocormia: from dystonia to myopathy. J Neurol Neurosurg Psychiatry , 83 (3) pp. 350-351. 10.1136/jnnp.2011.246561.

Doherty, KM; Silveira-Moriyama, L; Giladi, N; Bhatia, KP; Parton, M; Lees, AJ; (2012) Camptocormia: Don't forget muscle disease in the movement disorder clinic. Journal of Neurology , 259 (8) pp. 1752-1754. 10.1007/s00415-012-6448-z.

Doherty, KM; Silveira-Moriyama, L; Giladi, N; Bhatia, KP; Parton, M; Lees, AJ; (2012) Camptocormia: don't forget muscle disease in the movement disorder clinic. J Neurol , 259 (8) pp. 1752-1754. 10.1007/s00415-012-6448-z.

Doherty, KM; Silveira-Moriyama, L; Nisbet, A; Noyce, A; Quinn, N; Parton, M; Lees, AJ; (2012) CAMPTOCORMIA: WHAT IS THE CAUSE? In:

Doherty, KM; Silveira-Moriyama, L; Parkkinen, L; Healy, D; Farrell, M; Mencacci, NE; Ahmed, Z; (2012) A clinicopathological study of parkin-linked parkinsonism - A study of 5 cases and comparison with Parkinson's disease. In: MOVEMENT DISORDERS. (pp. S453 - S453).

Domijan, AM; Kovac, S; Abramov, AY; (2012) Impact of fumonisin B1 on glutamate toxicity and low magnesium-induced seizure activity in neuronal primary culture. Neuroscience , 202 pp. 10-16. 10.1016/j.neuroscience.2011.12.005.

Dubois, B; Tolosa, E; Katzenschlager, R; Emre, M; Lees, AJ; Schumann, G; Pourcher, E; (2012) Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study. Mov Disord , 27 (10) pp. 1230-1238. 10.1002/mds.25098.

Duran, R; McNeill, A; Mehta, A; Hughes, D; Cox, T; Deegan, P; Schapira, AH; (2012) Novel pathogenic mutations in the glucocerebrosidase locus. Mol Genet Metab , 106 (4) pp. 495-497. 10.1016/j.ymgme.2012.05.006. Gold open access

Duran, R; McNeill, A; Mehta, A; Hughes, D; Cox, T; Deegan, P; Schapira, AHV; (2012) Novel pathogenic mutations in the glucocerebrosidase locus. Molecular Genetics and Metabolism , 106 (4) pp. 495-497. 10.1016/j.ymgme.2012.05.006.

E

Eadie, MJ; Scott, AE; Lees, AJ; Woodward, M; (2012) William Gowers: the never completed third edition of the 'Bible of Neurology'. Brain , 135 (Pt 10) pp. 3178-3188. 10.1093/brain/aws181.

Eatough, V; Shaw, K; Lees, A; (2012) Banking on brains: insights of brain donor relatives and friends from an experiential perspective. Psychol Health , 27 (11) pp. 1271-1290. 10.1080/08870446.2012.669480.

Englund, E; Gustafson, L; Passant, U; Majounie, E; Renton, AE; Traynor, BJ; Rohrer, JD; (2012) Familial Lund frontotemporal dementia caused by C9ORF72 hexanucleotide expansion. Neurobiol Aging , 33 (8) 1850.e13-1850.e16. 10.1016/j.neurobiolaging.2012.02.019.

Esselens, C; Sannerud, R; Gallardo, R; Baert, V; Kaden, D; Serneels, L; De Strooper, B; (2012) Peptides based on the presenilin-APP binding domain inhibit APP processing and Aβ production through interfering with the APP transmembrane domain. FASEB J , 26 (9) pp. 3765-3778. 10.1096/fj.11-201368.

Everett, CM; Kara, E; Maresh, KE; Houlden, H; (2012) Clinical variability and L-Dopa responsive Parkinsonism in hereditary spastic paraplegia 11. Journal of Neurology , 259 (12) pp. 2726-2728. 10.1007/s00415-012-6642-z.

Everett, CM; Kara, E; Maresh, KE; Houlden, H; (2012) Clinical variability and L-Dopa responsive Parkinsonism in hereditary spastic paraplegia 11. J Neurol , 259 (12) pp. 2726-2728. 10.1007/s00415-012-6642-z.

F

Fahlke, C; Berggren, U; Berglund, KJ; Zetterberg, H; Blennow, K; Engel, JA; Balldin, J; (2012) Neuroendocrine assessment of serotonergic, dopaminergic, and noradrenergic functions in alcohol-dependent individuals. Alcohol Clin Exp Res , 36 (1) pp. 97-103. 10.1111/j.1530-0277.2011.01598.x.

Fassone, E; Taanman, JW; Sweeney, MG; Woodward, C; Hargreaves, IP; Hanna, MG; Taylor, RW; (2012) WHOLE EXOME SEQUENCING REVEALS THAT SUBUNIT MUTATIONS ARE PREVALENT IN COMPLEX I DEFICIENT LEIGH SYNDROME. Presented at: UNSPECIFIED.

Fawcett, KA; Murphy, SM; Polke, JM; Wray, S; Burchell, VS; Manji, H; Quinlivan, RM; (2012) Comprehensive analysis of the TRPV4 gene in a large series of inherited neuropathies and controls. Journal of Neurology, Neurosurgery and Psychiatry , 83 (12) pp. 1204-1209. 10.1136/jnnp-2012-303055.

Fawcett, KA; Murphy, SM; Polke, JM; Wray, S; Burchell, VS; Manji, H; Quinlivan, RM; (2012) Comprehensive analysis of the TRPV4 gene in a large series of inherited neuropathies and controls. J Neurol Neurosurg Psychiatry , 83 (12) pp. 1204-1209. 10.1136/jnnp-2012-303055.

Ferrari, R; Mok, K; Moreno, JH; Cosentino, S; Goldman, J; Pietrini, P; Mayeux, R; (2012) Screening for C9ORF72 repeat expansion in FTLD. Neurobiology of Aging , 33 (8) 10.1016/j.neurobiolaging.2012.02.017.

Ferrari, R; Mok, K; Moreno, JH; Cosentino, S; Goldman, J; Pietrini, P; Mayeux, R; (2012) Screening for C9ORF72 repeat expansion in FTLD. Neurobiol Aging , 33 (8) 1850.e1-1850.11. 10.1016/j.neurobiolaging.2012.02.017.

Ferrari, R; Moreno, JH; Minhajuddin, AT; O'Bryant, SE; Reisch, JS; Barber, RC; Momeni, P; (2012) Implication of common and disease specific variants in CLU, CR1, and PICALM. Neurobiology of Aging , 33 (8) 1846.e7-1846.e18. 10.1016/j.neurobiolaging.2012.01.110.

Fitzgerald, JC; Camprubi, MD; Dunn, L; Wu, HC; Ip, NY; Kruger, R; Martins, LM; (2012) Phosphorylation of HtrA2 by cyclin-dependent kinase-5 is important for mitochondrial function. Cell Death Differ , 19 (2) pp. 257-266. 10.1038/cdd.2011.90.

Foley, AR; Broomfield, AA; Pandraud, A; Johnson, JO; Singleton, AB; Hargreaves, IP; Land, JM; (2012) High-dose riboflavin therapy in Brown-Vialetto-Van Laere syndrome: clinical and biochemical improvement. In: (pp. S4-S4).

Fonteyn, EMR; Schmitz-Hubsch, T; Verstappen, CC; Baliko, L; Boesch, S; Bunn, L; Giunti, P; (2012) Prospective analysis of falls in spinocerebellar ataxias. In: (pp. S182-S182).

Foulds, PG; Yokota, O; Thurston, A; Davidson, Y; Ahmed, Z; Holton, J; Thompson, JC; (2012) Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies. Neurobiology of Disease , 45 (1) 188 - 195. 10.1016/j.nbd.2011.08.003. Green open access
file

Freeman, J; Kriston-Vizi, J; Lindenschmidt, I; Gewinner, C; Ketteler, R; (2012) Activation of autophagy limits ovarian cancer cell line growth. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE , 30 S16-S16.

Friedland, RP; Shah, JJ; Farrer, LA; Vardarajan, B; Rebolledo-Mendez, JD; Mok, K; Hardy, J; (2012) Behavioral variant frontotemporal lobar degeneration with amyotrophic lateral sclerosis with a chromosome 9p21 hexanucleotide repeat. Frontiers in Neurology , OCT 10.3389/fneur.2012.00136. Gold open access

G

Gallagher, DA; Goetz, CG; Stebbins, G; Lees, AJ; Schrag, A; (2012) Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease. Movement Disorders , 27 (1) pp. 79-83. 10.1002/mds.23939.

Gallagher, DA; Goetz, CG; Stebbins, G; Lees, AJ; Schrag, A; (2012) Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease. Mov Disord , 27 (1) pp. 79-83. 10.1002/mds.23939.

Gandhi, S; Abramov, AY; (2012) Mechanism of oxidative stress in neurodegeneration. Oxid Med Cell Longev , 2012 428010-. 10.1155/2012/428010. Gold open access

Gandhi, S; Vaarmann, A; Yao, Z; Duchen, MR; Wood, NW; Abramov, AY; (2012) Dopamine induced neurodegeneration in a PINK1 model of Parkinson's disease. PLoS One , 7 (5) , Article e37564. 10.1371/journal.pone.0037564. Green open access
file

Gardiner, A; Jaffer, F; Pittman, A; Gibbons, V; Wood, N; Hanna, M; Houlden, H; (2012) Next Generation Sequencing of Ion Channels in Neurological disorders. Presented at: UNSPECIFIED.

Gardiner, A; Kullmann, D; Wood, N; Ptacek, L; Houlden, H; Hanna, M; (2012) Episodic muscle and brain channels: Analysis of the PRRT2 gene and screening of a muscle channel panel. In: NEUROMUSCULAR DISORDERS. (pp. S17 - S17).

Gardiner, AR; Bhatia, KP; Stamelou, M; Dale, RC; Kurian, MA; Schneider, SA; Wali, GM; (2012) PRRT2 gene mutations From paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine. NEUROLOGY , 79 (21) pp. 2115-2121.

Gardiner, AR; Bhatia, KP; Stamelou, M; Dale, RC; Kurian, MA; Schneider, SA; Wali, GM; (2012) PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine. Neurology , 79 (21) pp. 2115-2121. 10.1212/WNL.0b013e3182752c5a.

Gaujoux-Viala, C; Knevel, R; Mandl, P; Nagy, G; Frank, M; Machado, P; Hatemi, G; (2012) Who are the young professionals working in the field of rheumatology in Europe and what are their needs? An EMEUNET (EMerging EUlar NETwork) survey. Ann Rheum Dis , 71 (8) pp. 1432-1433. 10.1136/annrheumdis-2011-201266.

Gegg, ME; Burke, D; Heales, SJ; Cooper, JM; Hardy, J; Wood, NW; Schapira, AH; (2012) Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains. Ann Neurol , 72 (3) pp. 455-463. 10.1002/ana.23614.

Gerrish, A; Russo, G; Richards, A; Moskvina, V; Ivanov, D; Harold, D; Sims, R; (2012) The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease. Journal of Alzheimer's Disease , 28 (2) pp. 377-387. 10.3233/JAD-2011-110824.

Gerrish, A; Russo, G; Richards, A; Moskvina, V; Ivanov, D; Harold, D; Sims, R; (2012) The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease. J Alzheimers Dis , 28 (2) pp. 377-387. 10.3233/JAD-2011-110824.

Gibbons, V; Labrum, RW; Haworth, A; Sweeney, MG; Wood, NW; Houlden, H; Hanna, MG; (2012) Episodic ataxia type 2-mutation analysis and screening recommendations. In: (pp. S87-S87).

Gisslén, M; Fuchs, D; Hagberg, L; Svennerholm, B; Zetterberg, H; (2012) Cerebrospinal fluid viral breakthrough in two HIV-infected subjects on darunavir/ritonavir monotherapy. Scand J Infect Dis , 44 (12) pp. 997-1000. 10.3109/00365548.2012.690526.

Giunti, P; Houlden, H; Gardner-Thorpe, C; Worth, PF; Johnson, J; Hilton, DA; Revesz, T; (2012) Spinocerebellar ataxia type 11. In: UNSPECIFIED (pp. 521-534).

Giunti, P; Nethisinghe, S; Clayton, LM; Vermeer, S; Chapple, JP; Reilly, MM; Bremner, F; (2012) DETECTING RETINAL CHANGES IN AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY (ARSACS) USING OPTICAL COHERENCE TOMOGRAPHY (OCT). In:

Glass, P; Lees, A; Bacellar, A; Zijlmans, J; Katzenschlager, R; Silveira-Moriyama, L; (2012) Clinical Features of Vascular Parkinsonism in Pathologically Confirmed Cases. Presented at: UNSPECIFIED.

Glass, PG; Lees, AJ; Bacellar, A; Zijlmans, J; Katzenschlager, R; Silveira-Moriyama, L; (2012) The clinical features of pathologically confirmed vascular parkinsonism. J Neurol Neurosurg Psychiatry , 83 (10) pp. 1027-1029. 10.1136/jnnp-2012-302828.

Glass, PG; Lees, AJ; Mathias, C; Mason, L; Best, C; Williams, DR; Katzenschlager, R; (2012) Olfaction in pathologically proven patients with multiple system atrophy. Movement Disorders , 27 (2) pp. 327-328. 10.1002/mds.23972.

Glodzik, L; Mosconi, L; Tsui, W; de Santi, S; Zinkowski, R; Pirraglia, E; Rich, KE; (2012) Alzheimer's disease markers, hypertension, and gray matter damage in normal elderly. Neurobiol Aging , 33 (7) pp. 1215-1227. 10.1016/j.neurobiolaging.2011.02.012.

Goate, A; Hardy, J; (2012) Twenty years of Alzheimer's disease-causing mutations. J Neurochem , 120 Su pp. 3-8. 10.1111/j.1471-4159.2011.07575.x.

Graves, T; Cha, Y-H; Hahn, A; Barohn, R; Amato, A; Griggs, R; Bundy, B; (2012) Episodic Ataxia Type 1: Characterization of the Disease and Its Effect on Quality of Life. In: NEUROLOGY.

Graves, T; Fialho, D; Smith, S; Cha, Y-H; Amato, A; Griggs, R; Bundy, B; (2012) EEG Abnormalities in the Episodic Ataxias. In: NEUROLOGY.

Gray, A; Nirmalananthan, N; Malik, B; Dick, J; Hanna, M; Greensmith, L; (2012) Targeting the endogenous stress response in a mouse model of SBMA. In: NEUROMUSCULAR DISORDERS. (pp. S12 - S12).

Guergueltcheva, V; Müller, JS; Dusl, M; Senderek, J; Oldfors, A; Lindbergh, C; Maxwell, S; (2012) Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations. J Neurol , 259 (5) pp. 838-850. 10.1007/s00415-011-6262-z.

Guerreiro, R; Kara, E; Le Ber, I; Bras, J; Rohrer, J; Taipa, R; Lashley, T; (2012) Genetic analysis of inherited leukodystrophies: genotype phenotype correlations in the CSF1R gene. In: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. (pp. 9 - 9).

Guerreiro, RJ; Gustafson, DR; Hardy, J; (2012) The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE. Neurobiology of Disease , 33 (3) 437 - 456. 10.1016/j.neurobiolaging.2010.03.025. Green open access
file

Guerreiro, RJ; Hardy, J; (2012) TOMM40 Association With Alzheimer Disease Tales of APOE and Linkage Disequilibrium. ARCHIVES OF NEUROLOGY , 69 (10) pp. 1243-1244. 10.1001/archneurol.2012.1935.

Guerreiro, RJ; Hardy, J; (2012) TOMM40 association with Alzheimer disease: tales of APOE and linkage disequilibrium. Arch Neurol , 69 (10) pp. 1243-1244. 10.1001/archneurol.2012.1935.

Guerreiro, RJ; Lohmann, E; Brás, JM; Gibbs, JR; Rohrer, JD; Gurunlian, N; Dursun, B; (2012) Using Exome Sequencing to Reveal Mutations in TREM2 Presenting as a Frontotemporal Dementia-like Syndrome Without Bone Involvement. Arch Neurol pp. 1-7. 10.1001/archneurol.2013.579.

Guerreiro, RJ; Lohmann, E; Kinsella, E; Brás, JM; Luu, N; Gurunlian, N; Dursun, B; (2012) Exome sequencing reveals an unexpected genetic cause of disease: NOTCH3 mutation in a Turkish family with Alzheimer's disease. Neurobiol Aging , 33 (5) 1008.e17-1008.e23. 10.1016/j.neurobiolaging.2011.10.009.

Guix, FX; Wahle, T; Vennekens, K; Snellinx, A; Chávez-Gutiérrez, L; Ill-Raga, G; Ramos-Fernandez, E; (2012) Modification of γ-secretase by nitrosative stress links neuronal ageing to sporadic Alzheimer's disease. EMBO Mol Med , 4 (7) pp. 660-673. 10.1002/emmm.201200243.

Gupta, K; Patani, R; Baxter, P; Serio, A; Story, D; Tsujita, T; Hayes, JD; (2012) Human embryonic stem cell derived astrocytes mediate non-cell-autonomous neuroprotection through endogenous and drug-induced mechanisms. Cell Death Differ , 19 (5) pp. 779-787. 10.1038/cdd.2011.154.

Gustavsson, J; Mehlig, K; Leander, K; Strandhagen, E; Björck, L; Thelle, DS; Lissner, L; (2012) Interaction of apolipoprotein E genotype with smoking and physical inactivity on coronary heart disease risk in men and women. Atherosclerosis , 220 (2) pp. 486-492. 10.1016/j.atherosclerosis.2011.10.011.

H

Haack, TB; Hogarth, P; Kruer, MC; Gregory, A; Wieland, T; Schwarzmayr, T; Graf, E; (2012) Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA. American Journal of Human Genetics , 91 (6) pp. 1144-1149. 10.1016/j.ajhg.2012.10.019.

Haack, TB; Hogarth, P; Kruer, MC; Gregory, A; Wieland, T; Schwarzmayr, T; Graf, E; (2012) Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA. Am J Hum Genet , 91 (6) pp. 1144-1149. 10.1016/j.ajhg.2012.10.019.

Hall, S; Öhrfelt, A; Constantinescu, R; Andreasson, U; Surova, Y; Bostrom, F; Nilsson, C; (2012) Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders. Arch Neurol , 69 (11) pp. 1445-1452. 10.1001/archneurol.2012.1654.

Hanna, MG; Kullmann, DM; (2012) Channelopathies. pp. 121-135. 10.1017/CBO9781139087711.009.

Hansson, O; Stomrud, E; Vanmechelen, E; Östling, S; Gustafson, DR; Zetterberg, H; Blennow, K; (2012) Evaluation of plasma Aβ as predictor of Alzheimer's disease in older individuals without dementia: a population-based study. J Alzheimers Dis , 28 (1) pp. 231-238. 10.3233/JAD-2011-111418.

Hardy, J; (2012) Alzheimer’s disease and related dementias. pp. 17-31. 10.1017/CBO9781139087711.003.

Hardy, J; (2012) CSF biomarking for diagnosis and treatment assessment in neurodegeneration. J Neurochem , 123 (3) pp. 339-341. 10.1111/j.1471-4159.2012.07928.x.

Hardy, J; (2012) Genetic analysis of disease in the era of whole genome analysis and public databases. Neurobiol Aging , 33 (4) 635-. 10.1016/j.neurobiolaging.2011.12.039.

Hardy, J; Revesz, T; (2012) The spread of neurodegenerative disease. N Engl J Med , 366 (22) pp. 2126-2128. 10.1056/NEJMcibr1202401.

Hernandez, DG; Nalls, MA; Moore, M; Chong, S; Dillman, A; Trabzuni, D; Gibbs, JR; (2012) Integration of GWAS SNPs and tissue specific expression profiling reveal discrete eQTLs for human traits in blood and brain. Neurobiology of Disease , 47 (1) 20 - 28. 10.1016/j.nbd.2012.03.020. Green open access
file

Hernandez, DG; Nalls, MA; Ylikotila, P; Keller, M; Hardy, JA; Majamaa, K; Singleton, AB; (2012) Genome Wide Assessment of Young Onset Parkinson's Disease from Finland. PLOS ONE , 7 (7) , Article e41859. 10.1371/journal.pone.0041859. Green open access
file

Hersheson, J; Haworth, A; Houlden, H; (2012) The inherited ataxias: genetic heterogeneity, mutation databases, and future directions in research and clinical diagnostics. Hum Mutat , 33 (9) pp. 1324-1332. 10.1002/humu.22132.

Hersheson, J; Hersheson, J; Pittman, A; Houlden, H; (2012) Developing a NGS screening panel for dominant cerebellar ataxia. In: JOURNAL OF MEDICAL GENETICS. (pp. S120 - S120).

Hersheson, J; Pittman, A; Houlden, H; (2012) Piloting targeted next-generation sequencing for screening the known ataxia genes: The next step for all diagnostic laboratories. In: MOVEMENT DISORDERS. (pp. S456 - S457).

Hersheson, JS; Mencacci, NE; Giunti, P; Wood, N; Houlden, H; (2012) Screening a UK cohort for spinocerebellar ataxia type 36 (SCA36). In: (pp. S183-S183).

Heslegrave, AJ; Kapoor, RR; Eaton, S; Chadefaux, B; Akcay, T; Simsek, E; Flanagan, SE; (2012) Leucine-sensitive hyperinsulinaemic hypoglycaemia in patients with loss of function mutations in 3-Hydroxyacyl-CoA Dehydrogenase. Orphanet J Rare Dis , 7 25-. 10.1186/1750-1172-7-25. Gold open access

Hiscock, A; Dewar, L; Parton, M; Machado, P; Hanna, M; Ramdharry, G; (2012) Frequency and circumstances of falls in people with Inclusion Body Myositis. In: NEUROMUSCULAR DISORDERS. (pp. S30 - S31).

Hobart, JC; Cano, SJ; Warner, TT; Thompson, AJ; (2012) What sample sizes for reliability and validity studies in neurology? J Neurol , 259 (12) pp. 2681-2694. 10.1007/s00415-012-6570-y.

Hobart, JC; Cano, SJ; Warner, TT; Thompson, AJ; (2012) What sample sizes for reliability and validity studies in neurology? Journal of Neurology 1 - 14.

Holmstrom, KM; Baird, L; Dinkova-Kostova, AT; Abramov, AY; (2012) Nrf2 Controls Mitochondrial Bioenergetics. BIOPHYSICAL JOURNAL , 102 (3) 573A - 573A.

Horga, A; Rayan, DLR; Haworth, A; Matthews, E; Fialho, D; Sud, R; Portaro, S; (2012) Prevalence study of skeletal muscle channelopathies in England. In: (pp. S17-S17).

Horga, A; Rayan, DLR; Matthews, E; Fialho, D; Sud, R; Haworth, A; Portaro, S; (2012) PREVALENCE STUDY OF SKELETAL MUSCLE CHANNELOPATHIES IN ENGLAND. In:

Houlden, H; (2012) A Commentary on 'Four novel C20ORF54 mutations identified in Brown-Vialetto-Van Laere syndrome patients.'. J Hum Genet , 57 (9) 555-. 10.1038/jhg.2012.88.

Houlden, H; (2012) Extending the clinical spectrum of pain channelopathies. Brain , 135 (Pt 2) pp. 313-316. 10.1093/brain/aws007.

Houlden, H; (2012) Sniffing out the cerebellum. J Neurol Neurosurg Psychiatry , 83 (10) pp. 952-953. 10.1136/jnnp-2012-303136.

Houlden, H; Singleton, AB; (2012) The genetics and neuropathology of Parkinson's disease. Acta Neuropathol , 124 (3) pp. 325-338. 10.1007/s00401-012-1013-5.

Huey, ED; Ferrari, R; Moreno, JH; Jensen, C; Morris, CM; Potocnik, F; Kalaria, RN; (2012) FUS and TDP43 genetic variability in FTD and CBS. Neurobiol Aging , 33 (5) 1016.e9-1016.17. 10.1016/j.neurobiolaging.2011.08.004.

Hölttä, M; Zetterberg, H; Mirgorodskaya, E; Mattsson, N; Blennow, K; Gobom, J; (2012) Peptidome analysis of cerebrospinal fluid by LC-MALDI MS. PLoS One , 7 (8) , Article e42555. 10.1371/journal.pone.0042555. Green open access
file

I

Ince-Dunn, G; Okano, HJ; Jensen, KB; Park, WY; Zhong, R; Ule, J; Mele, A; (2012) Neuronal Elav-like (Hu) proteins regulate RNA splicing and abundance to control glutamate levels and neuronal excitability. Neuron , 75 (6) pp. 1067-1080. 10.1016/j.neuron.2012.07.009.

International Stroke Genetics Consortium (ISGC), ; Wellcome Trust Case Control Consortium 2 (WTCCC2), ; Bellenguez, C; Bevan, S; Gschwendtner, A; Spencer, CC; Burgess, AI; (2012) Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet , 44 (3) pp. 328-333. 10.1038/ng.1081.

Ip, L; Cia-Viciano, F; Spanswick, V; Pouigiannis, G; Cantley, L; Hartley, J; Hochhauser, D; (2012) Loss of the tumour suppressor inositol polyphosphate 4-phosphatase type II in ovarian cancer-implications for therapy. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE , 30 S19-S19.

J

Jacobi, H; Hauser, TK; Giunti, P; Globas, C; Bauer, P; Schmitz-Hübsch, T; Baliko, L; (2012) Spinocerebellar ataxia types 1, 2, 3 and 6: the clinical spectrum of ataxia and morphometric brainstem and cerebellar findings. Cerebellum , 11 (1) pp. 155-166. 10.1007/s12311-011-0292-z.

Jaffer, F; Graves, T; Gibbons, V; Gardiner, A; Hersheson, J; Hanna, M; Houlden, H; (2012) Episodic ataxia: screening candidate genes and genetic analysis of families. Presented at: UNSPECIFIED.

Jaffer, F; Reilly, MM; Quinlivan, RR; Muntoni, F; Orrell, R; Wraige, E; Saha, R; (2012) AVOIDING UNPLANNED HOSPITAL ADMISSIONS IN PATIENTS WITH NEUROMUSCULAR DISEASES: A REGIONAL COLLABORATIVE AUDIT OF HOSPITAL ADMISSIONS. In:

Januário, F; Almeida, J; Serra, S; Amaral, C; Machado, P; Rodrigues, LA; (2012) [Characterization of patients with ankylosing spondylitis in hidrokinesitherapy - a multidimensional assessment]. Acta Med Port , 25 (5) pp. 301-307.

Jebelli, JD; Dihanich, S; Civiero, L; Manzoni, C; Greggio, E; Lewis, PA; (2012) GTP binding and intramolecular regulation by the ROC domain of Death Associated Protein Kinase 1. Sci Rep , 2 695-. 10.1038/srep00695. Gold open access

Johnson, JO; Gibbs, JR; Megarbane, A; Urtizberea, JA; Hernandez, DG; Foley, AR; Arepalli, S; (2012) Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease. Brain , 135 (Pt 9) pp. 2875-2882. 10.1093/brain/aws161.

Jonsson, M; Zetterberg, H; Rolstad, S; Edman, A; Gouw, AA; Bjerke, M; Lind, K; (2012) Low cerebrospinal fluid sulfatide predicts progression of white matter lesions: The LADIS study. Dement Geriatr Cogn Disord , 34 (1) pp. 61-67. 10.1159/000341576.

K

Kamynina, AV; Holmstrom, KM; Koroev, DO; Volpina, OM; Abramov, AY; (2012) Anti-peptide antibodies to synthetic fragments of alpha7-subunit acetylcholine receptor or prion protein protect cells against beta-amyloid toxicity. JOURNAL OF PEPTIDE SCIENCE , 18 S136 - S136.

Kara, E; Ling, H; Pittman, AM; Shaw, K; de Silva, R; Simone, R; Holton, JL; (2012) The MAPT p.A152T variant is a risk factor associated with tauopathies with atypical clinical and neuropathological features. Neurobioly of Aging , 33 (9) 2231.e7 - 2231.e14. 10.1016/j.neurobiolaging.2012.04.006. Green open access
file

Kara, E; Xiromerisiou, G; Paudel, R; Revesz, T; Holton, J; Lees, A; Wood, N; (2012) Comprehensive genetic investigation of NBIA and complex dystonia-parkinsonism. In: MOVEMENT DISORDERS. (pp. S459 - S459).

Keenan, BT; Shulman, JM; Chibnik, LB; Raj, T; Tran, D; Sabuncu, MR; Alzheimer's Disease Neuroimaging Initiative, ; (2012) A coding variant in CR1 interacts with APOE-ε4 to influence cognitive decline. Hum Mol Genet , 21 (10) pp. 2377-2388. 10.1093/hmg/dds054.

Keller, MF; Saad, M; Bras, J; Bettella, F; Nicolaou, N; Simón-Sánchez, J; Mittag, F; (2012) Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease. Hum Mol Genet , 21 (22) pp. 4996-5009. 10.1093/hmg/dds335.

Kilarski, LL; Pearson, JP; Newsway, V; Majounie, E; Knipe, MD; Misbahuddin, A; Chinnery, PF; (2012) Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease. Mov Disord , 27 (12) pp. 1522-1529. 10.1002/mds.25132.

Kinghorn, KJ; Kaliakatsos, M; Blakely, EL; Taylor, RW; Rich, P; Clarke, A; Omer, S; (2012) Hypertrophic olivary degeneration on magnetic resonance imaging in mitochondrial syndromes associated with POLG and SURF1 mutations. Journal of Neurology 1 - 7.

Kojovic, M; Sheerin, U; Rubio-Agusti, I; Bras, J; Wood, N; Houlden, H; Hardy, J; (2012) Young Onset Parkinson's Disease Due to Homozygous Duplication of SNCA in a Consanguineous Family from Pakistan. Presented at: UNSPECIFIED.

Kojovic, M; Sheerin, UM; Rubio-Agusti, I; Saha, A; Bras, J; Gibbons, V; Palmer, R; (2012) Young-onset parkinsonism due to homozygous duplication of α-synuclein in a consanguineous family. Movement disorders : official journal of the Movement Disorder Society , 27 (14) pp. 1827-1829. 10.1002/mds.25114.

Kojovic, M; Sheerin, UM; Rubio-Agusti, I; Saha, A; Bras, J; Gibbons, V; Palmer, R; (2012) Young-onset parkinsonism due to homozygous duplication of α-synuclein in a consanguineous family. Mov Disord , 27 (14) pp. 1829-1830. 10.1002/mds.25199. Green open access
file

Korkodilos, M; Hajioff, S; Gardner, C; Overett, S; Ibrahim, S; Jaffer, F; Hanna, MG; (2012) Audit of unplanned admissions in neuromuscular patients: a collaborative audit. Audit, Information and Analysis Unit / London Specialised Commissioning Group / MRC Centre for Neuromuscular Diseases: United Kingdom. Green open access
file

Kosicek, M; Zetterberg, H; Andreasen, N; Peter-Katalinic, J; Hecimovic, S; (2012) Elevated cerebrospinal fluid sphingomyelin levels in prodromal Alzheimer's disease. Neurosci Lett , 516 (2) pp. 302-305. 10.1016/j.neulet.2012.04.019.

Koutsis, G; Karadima, G; Pandraud, A; Sweeney, MG; Paudel, R; Houlden, H; Wood, NW; (2012) Genetic screening of Greek patients with Huntington’s disease phenocopies identifies an SCA8 expansion. J Neurol , 259 (9) pp. 1874-1878. 10.1007/s00415-012-6430-9.

Koutsis, G; Mok, K; Schottlaender, L; Polke, J; Panas, M; Houlden, H; (2012) High frequency of the expanded C9ORF72 hexanucleotide repeat in familial and sporadic Greek ALS patients. Presented at: UNSPECIFIED.

Koutsis, G; Pandraud, A; Polke, JM; Wood, NW; Panas, M; Karadima, G; Houlden, H; (2012) Novel peripheral myelin protein 22 (PMP22) micromutations associated with variable phenotypes in Greek patients with Charcot-Marie-Tooth disease. Brain , 135 (Pt 8) e217-6. 10.1093/brain/aws034.

Koutsis, G; Pemble, S; Sweeney, MG; Paudel, R; Wood, NW; Panas, M; Kladi, A; (2012) Analysis of spinocerebellar ataxias due to expanded triplet repeats in Greek patients with cerebellar ataxia. In: EUROPEAN JOURNAL OF NEUROLOGY. (pp. 731 - 731).

Koutsis, G; Pemble, S; Sweeney, MG; Paudel, R; Wood, NW; Panas, M; Kladi, A; (2012) Analysis of spinocerebellar ataxias due to expanded triplet repeats in Greek patients with cerebellar ataxia. J Neurol Sci , 318 (1-2) pp. 178-180. 10.1016/j.jns.2012.03.019.

Kovac, S; Domijan, AM; Walker, MC; Abramov, AY; (2012) Prolonged seizure activity impairs mitochondrial bioenergetics and induces cell death. J Cell Sci , 125 (Pt 7) pp. 1796-1806. 10.1242/jcs.099176.

Kruczyk, M; Zetterberg, H; Hansson, O; Rolstad, S; Minthon, L; Wallin, A; Blennow, K; (2012) Monte Carlo feature selection and rule-based models to predict Alzheimer's disease in mild cognitive impairment. J Neural Transm (Vienna) , 119 (7) pp. 821-831. 10.1007/s00702-012-0812-0.

Kruer, M; Jepperson, T; Steiner, R; Russman, B; Blasco, P; Fan, G; Pollock, J; (2012) Mutations in ADD3 Lead to Inherited Forms of Spastic Diplegia and Spastic Quadriplegia. In: ANNALS OF NEUROLOGY. (pp. S218 - S218).

Kruer, MC; Boddaert, N; Schneider, SA; Houlden, H; Bhatia, KP; Gregory, A; Anderson, JC; (2012) Neuroimaging features of neurodegeneration with brain iron accumulation. AJNR Am J Neuroradiol , 33 (3) pp. 407-414. 10.3174/ajnr.A2677.

Kruer, MC; Paudel, R; Wagoner, W; Sanford, L; Kara, E; Gregory, A; Foltynie, T; (2012) Analysis of ATP13A2 in large neurodegeneration with brain iron accumulation (NBIA) and dystonia-parkinsonism cohorts. Neuroscience Letters , 523 (1) pp. 35-38. 10.1016/j.neulet.2012.06.036.

Kruer, MC; Paudel, R; Wagoner, W; Sanford, L; Kara, E; Gregory, A; Foltynie, T; (2012) Analysis of ATP13A2 in large neurodegeneration with brain iron accumulation (NBIA) and dystonia-parkinsonism cohorts. Neurosci Lett , 523 (1) pp. 35-38. 10.1016/j.neulet.2012.06.036.

Krut, JJ; Zetterberg, H; Blennow, K; Cinque, P; Hagberg, L; Price, RW; Studahl, M; (2012) Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections. Journal of Neurology 1 - 7.

König, J; McGlincy, NJ; Ule, J; (2012) Analysis of Protein-RNA Interactions with Single-Nucleotide Resolution Using iCLIP and Next-Generation Sequencing. pp. 153-169. 10.1002/9783527644582.ch10.

L

Lace, G; Ince, PG; Brayne, C; Savva, GM; Matthews, FE; de Silva, R; Simpson, JE; (2012) Mesial temporal astrocyte tau pathology in the MRC-CFAS ageing brain cohort. Dement Geriatr Cogn Disord , 34 (1) pp. 15-24. 10.1159/000341581.

Laires, PA; Canhão, H; Araújo, D; Fonseca, JE; Machado, P; Mourão, AF; Ramiro, S; (2012) CoReumaPt protocol: the Portuguese cohort of rheumatic diseases. Acta Reumatol Port , 37 (1) pp. 18-24.

Landgren, S; von Otter, M; Palmér, MS; Zetterström, C; Nilsson, S; Skoog, I; Gustafson, DR; (2012) A novel ARC gene polymorphism is associated with reduced risk of Alzheimer's disease. J Neural Transm (Vienna) , 119 (7) pp. 833-842. 10.1007/s00702-012-0823-x.

Laura, M; Murphy, SM; Hornemann, T; Bode, H; Polke, J; Blake, J; Houlden, H; (2012) Hereditary sensory neuropathy type 1: correlation of severity and plasma atypical deoxy-sphyngoid bases. In: (pp. S18-S18).

Lee, H-Y; Huang, Y; Bruneau, N; Roll, P; Roberson, EDO; Hermann, M; Quinn, E; (2012) Mutations in the Gene PRRT2 Cause Paroxysmal Kinesigenic Dyskinesia with Infantile Convulsions. CELL REPORTS , 1 (1) pp. 2-12. 10.1016/j.celrep.2011.11.001. Gold open access

Lee, H-Y; Huang, Y; Bruneau, N; Roll, P; Roberson, EDO; Hermann, M; Quinn, E; (2012) Mutations in the Novel Protein PRRT2 Cause Infantile Convulsions with Paroxysmal Kinesigenic Dyskinesia. In: ANNALS OF NEUROLOGY. (pp. S59 - S59).

Lee, HY; Huang, Y; Bruneau, N; Roll, P; Roberson, ED; Hermann, M; Quinn, E; (2012) Mutations in the novel protein PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep , 1 (1) pp. 2-12. 10.1016/j.celrep.2011.11.001.

Lee, HY; Huang, Y; Bruneau, N; Roll, P; Roberson, ED; Hermann, M; Quinn, E; (2012) Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. In: (pp. pp. 2-12).

Lees, A; (2012) East meets west to provide the best for PD patients. Focus on Parkinson's Disease , 23 (1) 2-.

Lees, A; (2012) Two decades of evolving care with pump therapies - What have we learned? European Neurological Review , 7 (SUPPL.) pp. 5-7.

Lees, A; Costa, R; Oliveira, C; Lopes, N; Nunes, T; Soares-da-Silva, P; (2012) Design of a double-blind, placebo-controlled, phase-III trial in patients with Parkinson's disease and end-of-dose motor fluctuations: opicapone superiority vs. placebo. In: EUROPEAN JOURNAL OF NEUROLOGY. (pp. 695 - 695).

Lees, A; Costa, R; Oliveira, C; Lopes, N; Nunes, T; Soares-da-Silva, P; (2012) The design of a double-blind, placebo-controlled, multi-national phase-III trial in patients with Parkinson's disease and end-of-dose motor fluctuations: Opicapone superiority vs. placebo. In: (pp. S127-S127).

Lees, A; Fahn, S; Eggert, KM; Jankovic, J; Lang, A; Micheli, F; Maral Mouradian, M; (2012) Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's disease. Movement Disorders , 27 (2) pp. 284-288. 10.1002/mds.23983.

Lees, A; Fahn, S; Eggert, KM; Jankovic, J; Lang, A; Micheli, F; Mouradian, MM; (2012) Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's disease. Mov Disord , 27 (2) pp. 284-288. 10.1002/mds.23983.

Lees, AJ; (2012) Impact Commentaries. A modern perspective on the top 100 cited JNNP papers of all time: The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease: accuracy of clinical diagnosis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry , 83 (10) pp. 954-955. 10.1136/jnnp-2012-302969.

Lees, AJ; (2012) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry , 83 (10) pp. 954-955. 10.1136/jnnp-2012-302969.

Lees, AJ; Woodward, RM; Scott, AE; Eadie, MJ; (2012) W R Gowers 1895: two unpublished post-graduate lectures. Brain , 135 (Pt 10) pp. 3165-3177. 10.1093/brain/aws029.

Lescai, F; Bonfiglio, S; Bacchelli, C; Chanudet, E; Waters, A; Sisodiya, SM; Kasperavičiūtė, D; (2012) Characterisation and validation of insertions and deletions in 173 patient exomes. PLoS One , 7 (12) , Article e51292. 10.1371/journal.pone.0051292. Green open access
file

Lill, CM; Roehr, JT; McQueen, MB; Kavvoura, FK; Bagade, S; Schjeide, B-MM; Schjeide, LM; (2012) Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database. PLOS GENETICS , 8 (3) , Article e1002548. 10.1371/journal.pgen.1002548. Green open access
file

Lin, MT; Cantuti-Castelvetri, I; Lees, AJ; Beal, MF; Simon, DK; (2012) Reply. Annals of Neurology , 72 (5) pp. 823-824. 10.1002/ana.23739.

Lin, MT; Cantuti-Castelvetri, I; Lees, AJ; Beal, MF; Simon, DK; (2012) Somatic Mitochondrial DNA Mutations and Parkinsonism Reply. ANNALS OF NEUROLOGY , 72 (5) 823 - 824. 10.1002/ana.23739.

Lin, MT; Cantuti-Castelvetri, I; Zheng, K; Jackson, KE; Tan, YB; Arzberger, T; Lees, AJ; (2012) Somatic mitochondrial DNA mutations in early Parkinson and incidental Lewy body disease. Ann Neurol , 71 (6) pp. 850-854. 10.1002/ana.23568.

Ling, H; Massey, L; Lees, A; Brown, P; Day, B; (2012) Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease. MOVEMENT DISORDERS , 27 S384 - S385.

Ling, H; Massey, LA; Lees, AJ; Brown, P; Day, BL; (2012) Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease. Brain , 135 (Pt 4) pp. 1141-1153. 10.1093/brain/aws038.

Ling, H; Massey, LA; Lees, AJ; Brown, P; Day, BL; (2012) Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease. Brain , 135 (Pt 4) 1141 - 1153. 10.1093/brain/aws038.

Ling, H; Petrovic, I; Day, BL; Lees, AJ; (2012) Smoking-induced transient motor deterioration in a levodopa-treated patient with Parkinson's disease. Journal of Neurology , 259 (11) pp. 2419-2423. 10.1007/s00415-012-6515-5.

Ling, H; Petrovic, I; Day, BL; Lees, AJ; (2012) Smoking-induced transient motor deterioration in a levodopa-treated patient with Parkinson's disease. J Neurol , 259 (11) pp. 2419-2423. 10.1007/s00415-012-6515-5.

Ling, H; de Silva, R; Courtney, R; Massey, L; Bajaj, N; Lowe, J; Holton, J; (2012) Clinicopathological study of progressive supranuclear palsy presenting with corticobasal syndrome. In: MOVEMENT DISORDERS. (pp. S384 - S384).

Ling, H; de Silva, R; Massey, L; Bajaj, N; Lowe, J; Holton, J; Lees, A; (2012) Clinicopathological correlation of progressive supranuclear palsy presenting with corticobasal syndrome. In: (pp. p. 290).

Liu, Y-T; Laura, M; Wood, N; Reilly, MM; Houlden, H; (2012) Mutations of the kinesin family member 5A (KIF5A) gene in patients with pure or complex Charcot-Marie-Tooth type 2 (CMT2). In: (pp. S18-S18).

Liu, Y-T; Pittman, A; Hughes, D; Polke, JM; Sweeney, MG; Houlden, H; Reilly, MM; (2012) Application of targeted resequencing panels in genetic diagnosis of Charcot-Marie-Tooth disease. Presented at: UNSPECIFIED.

Lo, C; Shorvon, S; Davis, M; Houlden, H; Gibbons, V; Wood, N; (2012) Genetic linkage analysis of a large family with photoparoxysmal response. Epilepsy Res , 99 (1-2) pp. 38-45. 10.1016/j.eplepsyres.2011.10.013.

Loane, C; Politis, M; Wu, K; O'Sullivan, SS; Woodhead, Z; Lawrence, AD; Lees, AJ; (2012) Drug-cue elicited frontal and limbic dysfunction in Parkinson's disease patients with dopamine dysregulation syndrome. In: MOVEMENT DISORDERS. (pp. S245 - S245).

Lohmann, E; Guerreiro, RJ; Erginel-Unaltuna, N; Gurunlian, N; Bilgic, B; Gurvit, H; Hanagasi, HA; (2012) Identification of PSEN1 and PSEN2 gene mutations and variants in Turkish dementia patients. Neurobiol Aging , 33 (8) 1850.e17-1850.e27. 10.1016/j.neurobiolaging.2012.02.020.

Lubbe, SJ; Pittman, AM; Olver, B; Lloyd, A; Vijayakrishnan, J; Naranjo, S; Dobbins, S; (2012) The 14q22.2 colorectal cancer variant rs4444235 shows cis-acting regulation of BMP4. Oncogene , 31 (33) pp. 3777-3784. 10.1038/onc.2011.564.

Lubbe, SJ; Pittman, AM; Olver, B; Lloyd, A; Vijayakrishnan, J; Naranjo, S; Dobbins, S; (2012) The 14q22.2 colorectal cancer variant rs4444235 shows cis-acting regulation of BMP4. Oncogene , 31 (33) pp. 3777-3784. 10.1038/onc.2011.564.

Luk, C; Compta, Y; Magdalinou, N; Marti, MJ; Hondhamuni, G; Zetterberg, H; Blennow, K; (2012) Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies. Journal of Neurochemistry 10.1111/j.1471-4159.2012.07911.x.

M

Maccecchini, ML; Chang, MY; Pan, C; John, V; Zetterberg, H; Greig, NH; (2012) Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-β peptide and τ levels: target engagement, tolerability and pharmacokinetics in humans. J Neurol Neurosurg Psychiatry , 83 (9) pp. 894-902. 10.1136/jnnp-2012-302589.

Machado, P; Bernardo, A; Cravo, AR; Rodrigues, A; Malcata, A; Nour, D; Vieira-Sousa, E; (2012) Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis--December 2011 update. Acta Reumatol Port , 37 (1) pp. 40-47.

Machado, P; Bogas, M; Ribeiro, A; Costa, J; Neto, A; Sepriano, A; Raposo, A; (2012) 2011 Portuguese recommendations for the use of biological therapies in patients with psoriatic arthritis. Acta Reumatol Port , 37 (1) pp. 26-39.

Machado, P; Cortese, A; Morrow, J; Dewar, L; Hiscock, A; Miller, A; Brady, S; (2012) The Natural History of Sporadic Inclusion Body Myositis-an Observational Longitudinal Study. In: (pp. S99-S100).

Machado, P; Hudson, J; Miller, A; Morrow, J; Parton, M; Bushby, K; Hanna, M; (2012) VALOSIN CONTAINING PROTEIN (VCP) AND MYOFIBRILLAR MYOPATHIES (MFM) GENES' MUTATIONS ARE NOT ASSOCIATED WITH SPORADIC INCLUSION BODY MYOSITIS (sIBM). In:

Machado, P; Hudson, J; Miller, A; Morrow, J; Parton, M; Bushby, K; Hanna, MG; (2012) Myofibrillar myopathies (MFM), valosin containing protein (VCP) and glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase (GNE) genes' mutations are not associated with sporadic inclusion body myositis (sIBM). In: NEUROMUSCULAR DISORDERS. (pp. S30 - S30).

Machado, P; Landewé, RB; Braun, J; Baraliakos, X; Hermann, KG; Hsu, B; Baker, D; (2012) MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitor. Ann Rheum Dis , 71 (12) pp. 2002-2005. 10.1136/annrheumdis-2012-201999.

Machado, P; Santos, MJ; Fonseca, JE; (2012) [Recommendations of the Portuguese Society of Rheumatology: a contribution towards improving the quality of health care]. Acta Reumatol Port , 37 (1) pp. 7-8.

Magdalinou, NK; Luk, C; Compta, Y; Marti, MJ; Lees, AJ; de Silva, R; (2012) Novel method for quantification of 3R-and 4R-tau isoforms in the cerebrospinal fluid of patients with atypical parkinsonian syndromes. In: MOVEMENT DISORDERS. (pp. S385 - S386).

Mahoney, CJ; Beck, J; Rohrer, JD; Lashley, T; Mok, K; Shakespeare, T; Yeatman, T; (2012) Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain , 135 (3) 736 - 750. 10.1093/brain/awr361. Green open access
file

Majounie, E; Abramzon, Y; Renton, AE; Perry, R; Bassett, SS; Pletnikova, O; Troncoso, JC; (2012) Repeat expansion in C9ORF72 in Alzheimer's disease. N Engl J Med , 366 (3) pp. 283-284. 10.1056/NEJMc1113592.

Majounie, E; Renton, AE; Mok, K; Dopper, EG; Waite, A; Rollinson, S; Chiò, A; (2012) Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurology , 11 (4) 323 - 330. 10.1016/S1474-4422(12)70043-1. Green open access
file

Mandemakers, W; Snellinx, A; O'Neill, MJ; de Strooper, B; (2012) LRRK2 expression is enriched in the striosomal compartment of mouse striatum. Neurobiol Dis , 48 (3) pp. 582-593. 10.1016/j.nbd.2012.07.017.

Martins, S; Soong, BW; Wong, VC; Giunti, P; Stevanin, G; Ranum, LP; Sasaki, H; (2012) Mutational origin of Machado-Joseph disease in the Australian Aboriginal communities of Groote Eylandt and Yirrkala. Arch Neurol , 69 (6) pp. 746-751. 10.1001/archneurol.2011.2504.

Massey, LA; Micallef, C; Paviour, DC; O'Sullivan, SS; Ling, H; Williams, DR; Kallis, C; (2012) Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. Movement Disorders , 27 (14) 1754 - 1762. 10.1002/mds.24968.

Massey, LA; Miranda, MA; Zrinzo, L; Al-Helli, O; Parkes, HG; Thornton, JS; So, PW; (2012) High resolution MR anatomy of the subthalamic nucleus: imaging at 9.4 T with histological validation. Neuroimage , 59 (3) pp. 2035-2044. 10.1016/j.neuroimage.2011.10.016.

Matilde, L; Eichler, F; Hornemann, T; Murphy, SM; Polke, J; Bull, K; Houlden, H; (2012) HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 1: CORRELATION OF SEVERITY AND PLASMA ATYPICAL DEOXY-SPHYNGOID BASES. In:

Matsuki, T; Zaka, M; Guerreiro, R; van der Brug, MP; Cooper, JA; Cookson, MR; Hardy, JA; (2012) Identification of Stk25 as a genetic modifier of Tau phosphorylation in Dab1-mutant mice. PLoS One , 7 (2) , Article e31152. 10.1371/journal.pone.0031152. Green open access
file

Matta, S; Van Kolen, K; da Cunha, R; van den Bogaart, G; Mandemakers, W; Miskiewicz, K; De Bock, PJ; (2012) LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis. Neuron , 75 (6) pp. 1008-1021. 10.1016/j.neuron.2012.08.022.

Matthews, E; Plotz, PH; Portaro, S; Parton, M; Elliott, P; Humbel, RL; Holton, JL; (2012) A case of necrotizing myopathy with proximal weakness and cardiomyopathy. Neurology , 78 (19) pp. 1527-1532. 10.1212/WNL.0b013e3182553baa.

Mattsson, N; Andreasson, U; Carrillo, MC; Persson, S; Shaw, LM; Zegers, I; Zetterberg, H; (2012) Proficiency testing programs for Alzheimer's disease cerebrospinal fluid biomarkers. Biomark Med , 6 (4) pp. 401-407. 10.2217/bmm.12.41.

Mattsson, N; Olsson, M; Gustavsson, MK; Kosicek, M; Malnar, M; Månsson, JE; Blomqvist, M; (2012) Amyloid-β metabolism in Niemann-Pick C disease models and patients. Metab Brain Dis , 27 (4) pp. 573-585. 10.1007/s11011-012-9332-8.

Mattsson, N; Portelius, E; Rolstad, S; Gustavsson, M; Andreasson, U; Stridsberg, M; Wallin, A; (2012) Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment. J Alzheimers Dis , 30 (4) pp. 767-778. 10.3233/JAD-2012-120019.

Mattsson, N; Rajendran, L; Zetterberg, H; Gustavsson, M; Andreasson, U; Olsson, M; Brinkmalm, G; (2012) BACE1 inhibition induces a specific cerebrospinal fluid β-amyloid pattern that identifies drug effects in the central nervous system. PLoS One , 7 (2) , Article e31084. 10.1371/journal.pone.0031084. Green open access
file

Mattsson, N; Rosén, E; Hansson, O; Andreasen, N; Parnetti, L; Jonsson, M; Herukka, SK; (2012) Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology , 78 (7) pp. 468-476. 10.1212/WNL.0b013e3182477eed.

Mattsson, N; Zegers, I; Andreasson, U; Bjerke, M; Blankenstein, MA; Bowser, R; Carrillo, MC; (2012) Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42. Biomark Med , 6 (4) pp. 409-417. 10.2217/bmm.12.39.

Mattsson, N; Zetterberg, H; (2012) What is a certified reference material? Biomark Med , 6 (4) pp. 369-370. 10.2217/bmm.12.37.

Mattsson, N; Zetterberg, H; Bianconi, S; Yanjanin, NM; Fu, R; Månsson, JE; Porter, FD; (2012) Miglustat treatment may reduce cerebrospinal fluid levels of the axonal degeneration marker tau in niemann-pick type C. JIMD Rep , 3 pp. 45-52. 10.1007/8904_2011_47.

McGlincy, NJ; Valomon, A; Chesham, JE; Maywood, ES; Hastings, MH; Ule, J; (2012) Regulation of alternative splicing by the circadian clock and food related cues. Genome Biol , 13 (6) R54-. 10.1186/gb-2012-13-6-r54.

McNaughton, D; Knight, W; Guerreiro, R; Ryan, N; Lowe, J; Poulter, M; Nicholl, DJ; (2012) Duplication of amyloid precursor protein (APP), but not prion protein (PRNP) gene is a significant cause of early onset dementia in a large UK series. Neurobioly of Aging , 33 (2) 426.e13 - 426.e21. 10.1016/j.neurobiolaging.2010.10.010. Green open access
file

McNeill, A; Duran, R; Proukakis, C; Bras, J; Hughes, D; Mehta, A; Hardy, J; (2012) Hyposmia and cognitive impairment in Gaucher disease patients and carriers. Mov Disord , 27 (4) pp. 526-532. 10.1002/mds.24945.

Mead, S; Beck, J; Poulter, M; Rohrer, J; Adamson, G; Hensman, D; Polke, J; (2012) Large C9ORF72 hexanucleotide expansions arise spontaneously in the healthy population but can be distinguished from pathogenic mutations by Sothern Blotting. In: (pp. pp. 285-286).

Mencacci, NE; Labrum, R; Haworth, A; Sweeney, M; Pittman, A; Stamelou, M; Fletcher, NA; (2012) Is anything lying behind parkin heterozygous mutations? In: MOVEMENT DISORDERS. (pp. S462 - S463).

Michaki, V; Guix, FX; Vennekens, K; Munck, S; Dingwall, C; Davis, JB; Townsend, DM; (2012) Down-regulation of the ATP-binding cassette transporter 2 (Abca2) reduces amyloid-β production by altering Nicastrin maturation and intracellular localization. J Biol Chem , 287 (2) pp. 1100-1111. 10.1074/jbc.M111.288258.

Miller, A; Ahmed, M; Hanna, MG; Greensmith, L; (2012) DEVELOPING NEW THERAPEUTIC STRATEGIES FOR INCLUSION BODY MYOSITIS. In:

Mittag, F; Büchel, F; Saad, M; Jahn, A; Schulte, C; Bochdanovits, Z; Simón-Sánchez, J; (2012) Use of support vector machines for disease risk prediction in genome-wide association studies: Concerns and opportunities. Human Mutation , 33 (12) pp. 1708-1718. 10.1002/humu.22161.

Mittag, F; Büchel, F; Saad, M; Jahn, A; Schulte, C; Bochdanovits, Z; Simón-Sánchez, J; (2012) Use of support vector machines for disease risk prediction in genome-wide association studies: concerns and opportunities. Hum Mutat , 33 (12) pp. 1708-1718. 10.1002/humu.22161.

Mok, K; Traynor, BJ; Schymick, J; Tienari, PJ; Laaksovirta, H; Peuralinna, T; Myllykangas, L; (2012) Chromosome 9 ALS and FTD locus is probably derived from a single founder. Neurobiology of Disease , 33 (1) 209.e3 - 209.e8. 10.1016/j.neurobiolaging.2011.08.005. Green open access
file

Mok, KY; Koutsis, G; Schottlaender, LV; Polke, J; Panas, M; Houlden, H; (2012) High frequency of the expanded C9ORF72 hexanucleotide repeat in familial and sporadic Greek ALS patients. Neurobioly of Aging , 33 (8) 1851.e1 - 1851.e5. 10.1016/j.neurobiolaging.2012.02.021. Green open access
file

Morales-Briceño, H; Rodríguez-Violante, M; Cervantes-Arriaga, A; Irani, SR; Lees, AJ; Silveira-Moriyama, L; (2012) Opsoclonus myoclonus syndrome associated with GQ1b antibodies. Mov Disord , 27 (13) pp. 1615-1616. 10.1002/mds.25169.

Morrow, J; Sinclair, CDJ; Fischmann, A; Thornton, JS; Yousry, TA; Reilly, MM; Hanna, MG; (2012) MRI QUANTIFICATION OF LOWER LIMB MUSCLE FATTY ATROPHY: A POTENTIAL OUTCOME MEASURE IN CHRONIC NEUROMUSCULAR DISEASES. In:

Morrow, JM; Sinclair, CDJ; Fischmann, A; Thornton, JS; Reilly, MM; Hanna, MG; Yousry, TA; (2012) MRI quantification of abnormal muscle water distribution in chronic neuromuscular diseases: a sensitive biomarker. In: (pp. S33-S33).

Moscovich, M; Munhoz, R; Teive, H; Raskin, S; Liu, J; McFarland, K; Ashizawa, T; (2012) To Investigate Olfactory Impairment in Cerebellar Ataxia. In: NEUROLOGY.

Moscovich, M; Munhoz, RP; Teive, HA; Raskin, S; Carvalho, MDEJ; Barbosa, ER; Ranvaud, R; (2012) Olfactory impairment in familial ataxias. J Neurol Neurosurg Psychiatry , 83 (10) pp. 970-974. 10.1136/jnnp-2012-302770.

Moscovich, M; Munhoz, RP; Teive, HA; Raskin, S; De Carvalho, MJ; Barbosa, ER; Ranvaud, R; (2012) Olfactory impairment in familial ataxias. Journal of Neurology, Neurosurgery and Psychiatry , 83 (10) pp. 970-974. 10.1136/jnnp-2012-302770.

Movérare-Skrtic, S; Johansson, P; Mattsson, N; Hansson, O; Wallin, A; Johansson, JO; Zetterberg, H; (2012) Leukocyte telomere length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's disease: a pilot study. Exp Gerontol , 47 (2) pp. 179-182. 10.1016/j.exger.2011.12.005.

Mullin, S; Platts, A; Randhawa, K; Watts, P; (2012) Cerebral vasospasm and anterior circulation stroke secondary to an exacerbation of hereditary corproporphyria. Pract Neurol , 12 (6) pp. 384-387. 10.1136/practneurol-2012-000288.

Murphy, S; Pandraud, A; Liu, Y; Fawcett, K; Polke, JM; Davidson, G; Laura, M; (2012) CHARCOT-MARIE-TOOTH DISEASE: GENETIC DIAGNOSES IN A SPECIALIST CLINIC. In:

Murphy, SM; Davidson, GL; Brandner, S; Houlden, H; Reilly, MM; (2012) Mutation in FAM134B causing severe hereditary sensory neuropathy. Journal of Neurology, Neurosurgery and Psychiatry , 83 (1) pp. 119-120. 10.1136/jnnp.2010.228965.

Murphy, SM; Davidson, GL; Brandner, S; Houlden, H; Reilly, MM; (2012) Mutation in FAM134B causing severe hereditary sensory neuropathy. J Neurol Neurosurg Psychiatry , 83 (1) pp. 119-120. 10.1136/jnnp.2010.228965.

Murphy, SM; Laura, M; Ernst, D; Liu, Y-T; Blake, J; Donaghy, M; Winer, J; (2012) Clinical and genetic characterisation of hereditary sensory neuropathy type 1 caused by mutations in SPTLC2. In: (pp. S19-S19).

Murphy, SM; Laura, M; Fawcett, K; Pandraud, A; Liu, YT; Davidson, GL; Rossor, AM; (2012) Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing. J Neurol Neurosurg Psychiatry , 83 (7) pp. 706-710. 10.1136/jnnp-2012-302451.

Murphy, SM; Laura, M; Fawcett, K; Pandraud, A; Liu, YT; Davidson, GL; Rossor, AM; (2012) Charcot-Marie-Tooth disease: Frequency of genetic subtypes and guidelines for genetic testing. Journal of Neurology, Neurosurgery and Psychiatry , 83 (7) pp. 706-710. 10.1136/jnnp-2012-302451.

Murphy, SM; Ovens, R; Polke, J; Siskind, CE; Laurà, M; Bull, K; Ramdharry, G; (2012) X inactivation in females with X-linked Charcot-Marie-Tooth disease. Neuromuscular Disorders , 22 (7) 617 - 621. 10.1016/j.nmd.2012.02.009. Green open access
file

N

Nesbitt, V; Pitceathly, R; Cockell, S; Poulton, J; Rahman, S; Hanna, M; Turnbull, D; (2012) The medical research council neuromuscular centre for translational research mitochondrial disease patient cohort study UK: from conceptualisation to utilisation. Presented at: UNSPECIFIED.

Neselius, S; Brisby, H; Theodorsson, A; Blennow, K; Zetterberg, H; Marcusson, J; (2012) CSF-biomarkers in Olympic boxing: diagnosis and effects of repetitive head trauma. PLoS One , 7 (4) , Article e33606. 10.1371/journal.pone.0033606. Green open access
file

Nesic, I; Guix, FX; Vennekens, K; Michaki, V; Van Veldhoven, PP; Feiguin, F; De Strooper, B; (2012) Alterations in phosphatidylethanolamine levels affect the generation of Aβ. Aging Cell , 11 (1) pp. 63-72. 10.1111/j.1474-9726.2011.00760.x.

Nethisinghe, S; Menon, RP; Faggiano, S; Vannocci, T; Rezaei, H; Pemble, S; Sweeney, MG; (2012) The role of interruptions in the polyglutamine tract of ATXN1 in SCA1 pathology. In: (pp. S91-S91).

Nikitopoulou, I; Oikonomou, N; Karouzakis, E; Sevastou, I; Nikolaidou-Katsaridou, N; Zhao, Z; Mersinias, V; (2012) Autotaxin expression from synovial fibroblasts is essential for the pathogenesis of modeled arthritis. J Exp Med , 209 (5) pp. 925-933. 10.1084/jem.20112012.

Noyce, A; Bestwick, J; Hawkes, CH; Knowles, CH; Hardy, J; Lees, AJ; Silveira-Moriyama, L; (2012) AN ALGORITHM TO IDENTIFY INDIVIDUALS AT HIGH-RISK OF PARKINSON'S DISEASE IN THE COMMUNITY. In:

Noyce, A; Silveira-Moriyama, L; Lees, AJ; Schrag, A; Bestwick, J; Hawkes, CH; Giovannoni, G; (2012) A PILOT STUDY OF AN ALGORITHM DESIGNED TO IDENTIFY PARKINSON'S DISEASE IN THE EARLY, NON-MOTOR PHASE. In:

Noyce, A; Treacy, C; Budu, C; Fearnley, J; Lees, AJ; Giovannoni, G; (2012) THE NEW BRADYKINESIA AKINESIA INCOORDINATION (BRAIN) TEST: AN ONLINE TEST OF UPPER LIMB MOVEMENT. In:

Noyce, AJ; Bestwick, J; Silveira-Moriyama, L; Hawkes, CH; Giovannoni, G; Lees, AJ; Schrag, A; (2012) Risk factors and early non-motor features for Parkinson's disease: A systematic review and meta-analysis. In: MOVEMENT DISORDERS. (pp. S4 - S4).

Noyce, AJ; Bestwick, JP; Silveira-Moriyama, L; Hawkes, CH; Giovannoni, G; Lees, AJ; Schrag, A; (2012) Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Annals of Neurology , 72 (6) pp. 893-901. 10.1002/ana.23687.

Noyce, AJ; Bestwick, JP; Silveira-Moriyama, L; Hawkes, CH; Giovannoni, G; Lees, AJ; Schrag, A; (2012) Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol , 72 (6) pp. 893-901. 10.1002/ana.23687.

Noyce, AJ; Silveira-Moriyama, L; Gilpin, P; Ling, H; Howard, R; Lees, AJ; (2012) Severe dysphagia as a presentation of Parkinson's disease. Mov Disord , 27 (3) pp. 457-458. 10.1002/mds.24006.

Noyce, AJ; Treacy, C; Budu, C; Fearnley, J; Lees, AJ; Giovannoni, G; (2012) The new Bradykinesia Akinesia Incoordination (BRAIN) test: preliminary data from an online test of upper limb movement. Mov Disord , 27 (1) pp. 157-158. 10.1002/mds.23947.

O

O'Sullivan, SS; Cheshire, P; Djamshidian, A; Bertram, K; Williams, DR; Lees, AJ; Foltynie, T; (2012) Is the brain-derived neurotrophic factor (BDNF) Val66Met genetic polymorphism associated with impulsive-compulsive behaviours in Parkinson's disease? In: MOVEMENT DISORDERS. (pp. S464 - S465).

Olsson, B; Malmeström, C; Basun, H; Annas, P; Höglund, K; Lannfelt, L; Andreasen, N; (2012) Extreme stability of chitotriosidase in cerebrospinal fluid makes it a suitable marker for microglial activation in clinical trials. J Alzheimers Dis , 32 (2) pp. 273-276. 10.3233/JAD-2012-120931.

Ozawa, T; Revesz, T; Paviour, D; Lees, AJ; Quinn, N; Tada, M; Kakita, A; (2012) Difference in MSA phenotype distribution between populations: genetics or environment? J Parkinsons Dis , 2 (1) pp. 7-18. 10.3233/JPD-2012-11056.

P

Paisán-Ruiz, C; Li, A; Schneider, SA; Holton, JL; Johnson, R; Kidd, D; Chataway, J; (2012) Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations. Neurobiol Aging , 33 (4) pp. 814-823. 10.1016/j.neurobiolaging.2010.05.009.

Palmqvist, S; Hertze, J; Minthon, L; Wattmo, C; Zetterberg, H; Blennow, K; Londos, E; (2012) Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study. PLoS One , 7 (6) , Article e38639. 10.1371/journal.pone.0038639. Green open access
file

Pandraud, A; Clayton, P; Foley, AR; Muntoni, F; Johnson, JO; Singleton, AB; Reilly, MM; (2012) INVESTIGATION OF RIBOFLAVIN TRANSPORTER MUTATIONS IN BROWN-VIALETTO-VAN LAERE SYNDROME, A POTENTIALLY TREATABLE METABOLIC DISEASE. JOURNAL OF INHERITED METABOLIC DISEASE , 35 S18-S18.

Pandraud, A; Johnson, JO; Singleton, AB; Clayton, P; Land, J; Hargreaves, I; Foley, AR; (2012) Genetic and functional investigation of Brown-Vialetto-Van Laere syndrome and related neuropathies. In: (pp. S19-S20).

Papadopoulou, AS; Dooley, J; Linterman, MA; Pierson, W; Ucar, O; Kyewski, B; Zuklys, S; (2012) The thymic epithelial microRNA network elevates the threshold for infection-associated thymic involution via miR-29a mediated suppression of the IFN-α receptor. Nat Immunol , 13 (2) pp. 181-187. 10.1038/ni.2193.

Papkovskaia, TD; Chau, KY; Inesta-Vaquera, F; Papkovsky, DB; Healy, DG; Nishio, K; Staddon, J; (2012) G2019S leucine-rich repeat kinase 2 causes uncoupling protein-mediated mitochondrial depolarization. Hum Mol Genet , 21 (19) pp. 4201-4213. 10.1093/hmg/dds244. Gold open access

Parkinson, MH; Nethisinghe, S; Clayton, L; Vermeer, S; Chapple, JP; Reilly, M; Bremner, F; (2012) Retinal changes in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) and other genetic ataxias. In: (pp. S190-S190).

Parén, L; Palmqvist, L; Barkhordar, GS; Hellgren, M; Zetterberg, H; (2012) Pregnancy and a rare MTHFR haplotype. Acta Obstet Gynecol Scand , 91 (5) pp. 635-636. 10.1111/j.1600-0412.2012.01380.x.

Patani, R; Chandran, S; (2012) Experimental and therapeutic opportunities for stem cells in multiple sclerosis. Int J Mol Sci , 13 (11) pp. 14470-14491. 10.3390/ijms131114470.

Patani, R; Lewis, PA; Trabzuni, D; Puddifoot, CA; Wyllie, DJ; Walker, R; Smith, C; (2012) Investigating the utility of human embryonic stem cell-derived neurons to model ageing and neurodegenerative disease using whole-genome gene expression and splicing analysis. J Neurochem , 122 (4) pp. 738-751. 10.1111/j.1471-4159.2012.07825.x.

Patani, R; Sibley, CR; Chandran, S; Ule, J; (2012) Using human pluripotent stem cells to study post-transcriptional mechanisms of neurodegenerative diseases. Brain Res , 1462 pp. 129-138. 10.1016/j.brainres.2011.12.057.

Paudel, R; Hardy, J; Revesz, T; Holton, JL; Houlden, H; (2012) Review: Genetics and neuropathology of primary pure dystonia. Neuropathology and Applied Neurobiology , 38 (6) pp. 520-534. 10.1111/j.1365-2990.2012.01298.x.

Paudel, R; Hardy, J; Revesz, T; Holton, JL; Houlden, H; (2012) Review: genetics and neuropathology of primary pure dystonia. Neuropathol Appl Neurobiol , 38 (6) pp. 520-534. 10.1111/j.1365-2990.2012.01298.x.

Paudel, R; Revesz, T; Hardy, J; Holton, J; Houlden, H; (2012) Genetics and neuropathology of focal dystonia. In: MOVEMENT DISORDERS. (pp. S354 - S355).

Peall, K; Waite, A; Kurian, M; Wardle, M; Hedderly, T; Lin, JP; Smith, M; (2012) Myoclonus dystonia syndrome: SGCE mutations and psychiatric disease. In: JOURNAL OF NEUROLOGY. (pp. S30 - S30).

Peall, K; Waite, AJ; Kurian, MA; Hedderly, T; Smith, M; Lin, JP; Warner, TT; (2012) MYOCLONUS DYSTONIA: A CLINICAL AND GENETIC DESCRIPTION. In:

Petkova, VI; Zetterberg, H; Ehrsson, HH; (2012) Rubber hands feel touch, but not in blind individuals. PLoS One , 7 (4) , Article e35912. 10.1371/journal.pone.0035912. Green open access
file

Petrovic, IN; Ling, H; Asi, Y; Ahmed, Z; Kukkle, PL; Hazrati, LN; Lang, AE; (2012) Multiple system atrophy-parkinsonism with slow progression and prolonged survival: a diagnostic catch. Mov Disord , 27 (9) pp. 1186-1190. 10.1002/mds.25115.

Piceathly, RDS; Smith, C; Fratter, C; Blakely, EL; Alston, CL; Deschauer, M; Horvath, R; (2012) Expanding the phenotypic and genotypic spectrum of adult RRM2B-related mitochondrial disease. In: (pp. S23-S23).

Pillai, A; Bruno, D; Sarreal, AS; Hernando, RT; Saint-Louis, LA; Nierenberg, J; Ginsberg, SD; (2012) Plasma BDNF levels vary in relation to body weight in females. PLoS One , 7 (7) , Article e39358. 10.1371/journal.pone.0039358. Green open access
file

Pitceathly, RD; Murphy, SM; Cottenie, E; Chalasani, A; Sweeney, MG; Woodward, C; Mudanohwo, EE; (2012) Genetic dysfunction of MT-ATP6 causes axonal Charcot-Marie-Tooth disease. In: (pp. pp. 1145-1154).

Pitceathly, RD; Rahman, S; Hanna, MG; (2012) Single deletions in mitochondrial DNA--molecular mechanisms and disease phenotypes in clinical practice. Neuromuscular Disorders , 22 (7) 577 - 586. 10.1016/j.nmd.2012.03.009. Green open access
file

Pitceathly, RD; Smith, C; Fratter, C; Alston, CL; He, L; Craig, K; Blakely, EL; (2012) Adults with RRM2B-related mitochondrial disease have distinct clinical and molecular characteristics. Brain , 135 (11) 3392 -3403. 10.1093/brain/aws231. Green open access
file

Pitceathly, RDS; Murphy, SM; Cottenie, E; Chalasani, A; Sweeney, MG; Woodward, C; Mudanohwo, EE; (2012) Genetic dysfunction of MT-ATP6 causes axonal Charcot-Marie-Tooth disease. NEUROLOGY , 79 (11) pp. 1145-1154.

Pitceathly, RDS; Tomlinson, SE; Hargreaves, I; Bhardwaj, N; Holton, JL; Evans, J; Smith, C; (2012) NOVEL DOMINANT POLG MUTATIONS CAUSE DISTAL MYOPATHY. In: (pp. S119-S119).

Pittman, A; Mencacci, N; Sheerin, U; Charlesworth, G; Deborah, H; Haworth, A; Sweeney, M; (2012) A comprehensive diagnostic test for familial and early onset Parkinson's disease based on next-generation sequencing. Presented at: UNSPECIFIED.

Plagnol, V; Curtis, J; Epstein, M; Mok, KY; Stebbings, E; Grigoriadou, S; Wood, NW; (2012) A robust model for read count data in exome sequencing experiments and implications for copy number variant calling. Bioinformatics , 28 (21) 2747 - 2754. 10.1093/bioinformatics/bts526. Gold open access
filefile

Plun-Favreau, H; Burchell, VS; Holmström, KM; Yao, Z; Deas, E; Cain, K; Fedele, V; (2012) HtrA2 deficiency causes mitochondrial uncoupling through the F₁F₀-ATP synthase and consequent ATP depletion. Cell Death and Disease , 3 , Article e335. 10.1038/cddis.2012.77. Green open access
file

Politis, M; Loane, C; Wu, K; O'Sullivan, S; Woodhead, Z; Kiferle, L; Lawrence, AD; (2012) Neural correlates of hypersexuality in Parkinson's disease. In: MOVEMENT DISORDERS. (pp. S250 - S250).

Polke, J; Mencacci, N; Stamelou, M; Sweeney, MG; Manji, H; Wood, NW; Bhatia, KP; (2012) Transcript analysis of a variably-penetrant GTP cyclohydrolase intronic splicing mutation. Presented at: UNSPECIFIED.

Polke, J; Mok, K; Poulter, M; Lashley, T; Beck, J; Wood, NW; Hardy, J; (2012) Diagnostic testing for the frontotemporal dementia/amyotrophic lateral sclerosis (GGGGCC)n expansion in C9orf72. In: (pp. S122-S122).

Pomara, N; Bruno, D; Sarreal, AS; Hernando, RT; Nierenberg, J; Petkova, E; Sidtis, JJ; (2012) Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder. Am J Psychiatry , 169 (5) pp. 523-530. 10.1176/appi.ajp.2011.11081153.

Portelius, E; Gustavsson, MK; Zetterberg, H; Andreasson, U; Blennow, K; (2012) Evaluation of the performance of novel Aβ isoforms as theragnostic markers in Alzheimer's disease: from the cell to the patient. Neurodegener Dis , 10 (1-4) pp. 138-140. 10.1159/000334537.

Portelius, E; Zetterberg, H; Dean, RA; Marcil, A; Bourgeois, P; Nutu, M; Andreasson, U; (2012) Amyloid-β(1-15/16) as a marker for γ-secretase inhibition in Alzheimer's disease. J Alzheimers Dis , 31 (2) pp. 335-341. 10.3233/JAD-2012-120508.

Pradeepa, MM; Sutherland, HG; Ule, J; Grimes, GR; Bickmore, WA; (2012) Psip1/Ledgf p52 binds methylated histone H3K36 and splicing factors and contributes to the regulation of alternative splicing. PLoS Genetics , 8 (5) , Article e1002717. 10.1371/journal.pgen.1002717. Green open access
file

Pressey, SN; Smith, DA; Wong, AM; Platt, FM; Cooper, JD; (2012) Early glial activation, synaptic changes and axonal pathology in the thalamocortical system of Niemann-Pick type C1 mice. Neurobiology of Disease , 45 (3) 1086 - 1100. 10.1016/j.nbd.2011.12.027. Green open access
file

Preza, E; Wray, S; Mahoney, C; Ryan, N; Liang, Y; Isaacs, A; Chio, A; (2012) Creation of a Fibroblast Resource for Dementia Research. In: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. (pp. 65 - 65).

Proukakis, C; Katsianou, M; Hummel, A; Brier, T; Houlden, H; Cooper, JM; Schapira, AH; (2012) A Novel Alpha-Synuclein Missense Mutation in Parkinson's Disease. In: ANNALS OF NEUROLOGY. (pp. S130 - S130).

Proukakis, C; Moore, D; Labrum, R; Wood, NW; Houlden, H; (2012) HEREDITARY SPASTIC PARAPLEGIA CAUSED BY SPASTIN (SPAST, SPG4) MUTATIONS IS FOUND MORE OFTEN IN MALES: REPORT OF NOVEL MUTATIONS FROM ONE CENTRE, AND REVIEW OF PUBLISHED LITERATURE. In:

Pulkes, T; Dejthevaporn, C; Apiwattanakul, M; Papsing, C; Hanna, MG; (2012) Paroxysmal neuromyotonia: A new sporadic channelopathy. NEUROMUSCULAR DISORDERS , 22 (6) 479 - 482. 10.1016/j.nmd.2012.01.004. Green open access
file

R

Raheem, O; Penttila, S; Suominen, T; Kaakinen, M; Burge, J; Haworth, A; Sud, R; (2012) New immunohistochemical method for improved myotonia and chloride channel mutation diagnostics. Presented at: UNSPECIFIED.

Raheem, O; Penttilä, S; Suominen, T; Kaakinen, M; Burge, J; Haworth, A; Sud, R;